OUTCOME IN PEMETREXED/CISPLATIN-TREATED NON-SMALL-CELL LUNG CANCER (NSCLC) PATIENTS ACCORDING TO MRNA EXPRESSION LEVELS OF BRCA1, TS, AEG1 AND REV3

被引：0

作者：

Massuti, Bartomeu ^{[1
]}

Lopez-Vivanco, Guillermo ^{[2
]}

Marti, Thomas M. ^{[3
]}

Kotov, Ilya ^{[4
]}

Chaib, Imane ^{[5
]}

Ponce-Aix, Santiago ^{[6
]}

Garcia-Campelo, Rosario ^{[7
]}

Miguel Sanchez, Jose ^{[8
]}

Artal, Angel ^{[9
]}

Bover, Isabel ^{[10
]}

Taron, Miquel ^{[5
]}

Sanchez-Ronco, Maria ^{[11
]}

Rolfo, Christian ^{[12
]}

Stahel, Rolf ^{[4
]}

Rosell, Rafael ^{[5
]}

机构：

[1] Hosp Gen Alicante, Alicante, Spain

[2] Hosp Cruces Barakaldo, Vizcaya, Spain

[3] Univ Hosp Bern, Dept Clin Res, Lab Thorac Surg, Bern, Switzerland

[4] Univ Zurich Hosp, Clin & Policlin Oncol, Zurich, Switzerland

[5] Catalan Inst Oncol, Barcelona, Spain

[6] Hosp 12 Octubre, Madrid, Spain

[7] Complejo Hosp A Coruna, La Coruna, Spain

[8] MD Anderson Canc Ctr, Madrid, Spain

[9] Hosp Univ Miguel Servet, Zaragoza, Spain

[10] Hosp Son Llatzer, Palma de Mallorca, Spain

[11] Univ Alcala de Henares, E-28801 Alcala De Henares, Spain

[12] Univ Antwerp Hosp, Antwerp, Belgium

来源：

关键词：

REV3; BRCA1; NSCLC; AEG1;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P3.01-015

引用

页码：S1040 / S1041

页数：2